Molecular Partners Ag (MOLN) Price to Earnings (2021 - 2026)
Molecular Partners Ag's (MOLN) quarterly Price to Earnings came in at 9.1 in Q2 2026, down 45.46% year-over-year from 16.69 in Q2 2025, and up 4.61% quarter-over-quarter from 9.54 in Q1 2026.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Price to Earnings (2021 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Price to Earnings for 6 consecutive years, with 9.1 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Earnings fell 45.46% year-over-year to 9.1 in Q2 2026; TTM through Jun 2026 was 2.42, a 17.78% decrease from a year earlier, with the FY2025 full-year figure at 1.82, up 52.62% from the prior year.
- Price to Earnings was 9.1 for Q2 2026 at Molecular Partners Ag, up from 9.54 in the prior quarter.
- Over five years, Price to Earnings peaked at 4.0 in Q1 2022 and troughed at 46.69 in Q2 2022.
- A 5-year average of 12.37 and a median of 11.32 in 2023 frame the typical range for Price to Earnings.
- The widest YoY moves for Price to Earnings: up 72.99% in 2023, down 440.2% in 2023.
- Over 5 years, Price to Earnings stood at 13.05 in 2022, then soared by 47.76% to 6.82 in 2023, then slumped by 119.4% to 14.96 in 2024, then advanced by 25.6% to 11.13 in 2025, then climbed by 18.22% to 9.1 in 2026.
- The last three Price to Earnings figures came in at 9.1 (Q2 2026), 9.54 (Q1 2026), and 11.13 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Molecular Partners Ag | 156.54 Mn | 156.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.10 |
| Mar 31, 2026 | -9.54 |
| Dec 31, 2025 | -11.13 |
| Sep 30, 2025 | -10.12 |
| Jun 30, 2025 | -6.26 |
| Mar 31, 2025 | -8.39 |
| Dec 31, 2024 | -14.96 |
| Sep 30, 2024 | -9.76 |
| Jun 30, 2024 | -15.76 |
| Mar 31, 2024 | -11.76 |
| Dec 31, 2023 | -6.82 |
| Sep 30, 2023 | -11.52 |
| Jun 30, 2023 | -12.61 |
| Mar 31, 2023 | -13.62 |
| Dec 31, 2022 | -13.05 |
| Sep 30, 2022 | -15.65 |
| Jun 30, 2022 | -46.69 |
| Mar 31, 2022 | 4.00 |
| Dec 31, 2021 | -31.91 |
| Sep 30, 2021 | -42.62 |